CLV — Clover Share Price
0.000.00%
Last trade - 00:00- AU$80.58m
- AU$71.23m
- AU$62.21m
- 98
- 79
- 82
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.38 | ||
| PEG Ratio (f) | 0.39 | ||
| EPS Growth (f) | 46.85% | ||
| Dividend Yield (f) | 3.35% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.19 | ||
| Price to Tang. Book | 1.22 | ||
| Price to Free Cashflow | 4.35 | ||
| Price to Sales | 1.11 | ||
| EV to EBITDA | 9.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.47% | ||
| Return on Equity | 6.8% | ||
| Operating Margin | 9.43% | ||
Financial Summary
| Year End 31st Jul | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 88.28 | 60.51 | 70.66 | 79.88 | 62.21 | 78.89 | 84.95 | -4.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +23.52 | -51.87 | +23.48 | -7.93 | -64.03 | +110.17 | +35.48 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clover Corporation Limited is focused on technology, new product development and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. The Company’s microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Directors
- Rupert Harrington NEC
- Peter Davey CEO
- Andrew Allibon CFO
- G Elliott OTH
- C. Patch OTH
- S. Phoothong OTH
- D. Pierotti OTH
- Ian Glasson DRC
- Simon Green DRC
- Graeme Billings NID
- Last Annual
- July 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- September 29th, 1988
- Public Since
- November 30th, 1999
- No. of Shareholders
- 3,377
- No. of Employees
- 60
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 166,999,341
- Address
- Altona North, 39 Pinnacle Road, MELBOURNE, 3025
- Web
- https://www.clovercorp.com.au/en/
- Phone
- +61 383475000
- Auditors
- PKF Melbourne Audit & Assurance Pty Ltd
Upcoming Events for CLV
Similar to CLV
A2 Milk
Australian Stock Exchange - SEATS
Australian Agricultural
Australian Stock Exchange - SEATS
Australian Agricultural Projects
Australian Stock Exchange - SEATS
Australian Dairy Nutritionals
Australian Stock Exchange - SEATS
Bega Cheese
Australian Stock Exchange - SEATS
FAQ
What is the Clover share price?
As of Today at 19:59 UTC, shares in Clover are trading at AU$0.48. This share price information is delayed by 15 minutes.
How has the Clover share price performed this year?
Shares in Clover last closed at AU$0.48 and the price had moved by -8.1% over the past 365 days. In terms of relative price strength the Clover share price has underperformed the ASX All Ordinaries Index by -9.47% over the past year.
What are the analyst and broker recommendations for Clover?
The overall consensus recommendation for Clover is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Clover dividend yield?
The Clover dividend yield is 3.11% based on the trailing twelve month period.
Does Clover pay a dividend?
Last year, Clover paid a total dividend of AU$0.02, and it currently has a trailing dividend yield of 3.11%.Looking ahead, the next dividend pay date is 2025-04-24.
When does Clover next pay dividends?
We do not have data on when Clover is to next pay dividends. The historic dividend yield on Clover shares is currently 3.11%.
How do I buy Clover shares?
To buy shares in Clover you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clover?
As of the previous close price of AU$0.48, shares in Clover had a market capitalisation of AU$80.58m.
Where are Clover shares listed?
Here are the trading details for Clover:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CLV
What kind of share is Clover?
Based on an overall assessment of its quality, value and momentum Clover is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clover share price forecast for 2025?
The analyst consensus target price for shares in Clover is AU$0.60. That is 24.35% above the last closing price of AU$0.48.
Analysts covering Clover currently have a consensus Earnings Per Share (EPS) forecast of AU$0.03 for the next financial year.
Find out moreWhat is the trend in the Clover share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clover. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -12.1%.
As of the last closing price of AU$0.48, shares in Clover were trading +4.59% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clover PE Ratio?
The Clover PE ratio based on its reported earnings over the past 12 months is 12.38. The shares last closed at AU$0.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clover?
Clover's management team is headed by:
- Rupert Harrington - NEC
- Peter Davey - CEO
- Andrew Allibon - CFO
- G Elliott - OTH
- C. Patch - OTH
- S. Phoothong - OTH
- D. Pierotti - OTH
- Ian Glasson - DRC
- Simon Green - DRC
- Graeme Billings - NID